| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Austria | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | Australia | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Biotechnology | |
| #2 | Measurement | |
| #3 | Pharmaceuticals |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Peptides | |
| #3 | Microorganisms | |
| #4 | Medical preparations | |
| #5 | Measuring microorganism processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Zlabinger Gerhard J | 4 |
| #2 | Stockinger Hannes | 4 |
| #3 | Szekeres Andreas | 4 |
| #4 | Kasinrerk Watchara | 3 |
| #5 | Drbal Karel | 3 |
| #6 | Leksa Vladimir | 3 |
| #7 | Khunkaewla Panida | 3 |
| #8 | Hofer-Warbinek Renate | 3 |
| #9 | Chiampanichayakul Sawitree | 3 |
| #10 | Moonsom Seangduen | 3 |
| Publication | Filing date | Title |
|---|---|---|
| AT502722A1 | Use of interferone induced gene 12 (isg 12, ifi 27) to modulate transcriptional activities of nuclear receptors | |
| ATA17772002A | Monoclonal antibodies to the na, k-atphase-beta-3 sub-unit and its use as therapeutic | |
| ATA17442001A | STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF CDw92 | |
| AT500023A1 | Functional screen for transcriptor factors |